In contrast, although sacubitril at higher doses reduced AngII-induced hypertension, the drug had minimal benefits on other AngII-induced responses when administered alone and did not improve effectiveness of AT1R antagonism in combination therapy. The gene discussed is AGT; the disease is hypertensive disorder.